FRA:FRE - Fresenius SE & Co KGaA Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€68.78 +0.98 (+1.45 %)
(As of 07/17/2018 04:00 PM ET)
Previous Close€67.80
Today's Range€67.64 - €69.02
52-Week Range€60.16 - €80.00
Volume958,318 shs
Average VolumeN/A
Market Capitalization$35.76 billion
P/E RatioN/A
Dividend Yield1.16%
BetaN/A
Fresenius SE & Co KGaA logoFresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany.

Receive FRE News and Ratings via Email

Sign-up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange FRA
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolFRA:FRE
CUSIPN/A
Phone+49-6172-6080

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares554,300,000
Market Cap$35,760.00

The Truth About Cryptocurrencies

Fresenius SE & Co KGaA (FRA:FRE) Frequently Asked Questions

What is Fresenius SE & Co KGaA's stock symbol?

Fresenius SE & Co KGaA trades on the FRA under the ticker symbol "FRE."

What price target have analysts set for FRE?

21 equities research analysts have issued 1-year target prices for Fresenius SE & Co KGaA's shares. Their predictions range from €59.00 to €85.00. On average, they anticipate Fresenius SE & Co KGaA's stock price to reach €78.52 in the next year. This suggests a possible upside of 14.2% from the stock's current price. View Analyst Ratings for Fresenius SE & Co KGaA.

What is the consensus analysts' recommendation for Fresenius SE & Co KGaA?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co KGaA in the last year. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are Fresenius SE & Co KGaA's key executives?

Fresenius SE & Co KGaA's management team includes the folowing people:
  • Gerd Krick, Chairman of the Supervisory Board
  • Stephan Sturm, Chief Executive Officer (Age 52)
  • Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee Representative
  • Juergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board
  • Francesco De Meo, Member of the Management Board, Chief Executive Officer of Fresenius Helios
  • Mats Christer Henriksson, Member of the Management Board, Chief Executive Officer Fresenius Kabi
  • Rice Powell, Member of the Management Board, Chief Executive Officer of Fresenius Medical Care (Age 61)
  • Ernst Wastler, Member of the Management Board, Chief Executive Officer Fresenius Vamed
  • D. Michael Albrecht, Member of the Supervisory Board
  • Michael Diekmann, Member of the Supervisory Board (Age 63)

Has Fresenius SE & Co KGaA been receiving favorable news coverage?

Headlines about FRE stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fresenius SE & Co KGaA earned a daily sentiment score of 0.10 on Accern's scale. They also assigned press coverage about the company an impact score of 44.94 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

What is Fresenius SE & Co KGaA's stock price today?

One share of FRE stock can currently be purchased for approximately €68.78.

How big of a company is Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA has a market capitalization of $35.76 billion.

How can I contact Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA's mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The company can be reached via phone at +49-6172-6080.


MarketBeat Community Rating for Fresenius SE & Co KGaA (FRA FRE)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  289
MarketBeat's community ratings are surveys of what our community members think about Fresenius SE & Co KGaA and other stocks. Vote "Outperform" if you believe FRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FRE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.